Progyny, Inc. Stock price

Equities

PGNY

US74340E1038

Managed Healthcare

Market Closed - Nasdaq 04:30:00 2024-03-28 pm EDT 5-day change 1st Jan Change
38.15 USD +0.42% Intraday chart for Progyny, Inc. +2.97% +2.61%
Sales 2024 * 1.3B Sales 2025 * 1.57B Capitalization 3.68B
Net income 2024 * 70M Net income 2025 * 105M EV / Sales 2024 * 2.63 x
Net cash position 2024 * 263M Net cash position 2025 * 481M EV / Sales 2025 * 2.04 x
P/E ratio 2024 *
55.9 x
P/E ratio 2025 *
37.7 x
Employees 565
Yield 2024 *
-
Yield 2025 *
-
Free-Float 91.36%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.42%
1 week+2.97%
Current month+4.46%
1 month+10.10%
3 months+1.06%
6 months+10.93%
Current year+2.61%
More quotes
1 week
36.65
Extreme 36.65
38.98
1 month
33.55
Extreme 33.55
38.98
Current year
33.07
Extreme 33.07
42.08
1 year
29.44
Extreme 29.44
44.95
3 years
25.67
Extreme 25.67
68.32
5 years
13.29
Extreme 13.29
68.32
10 years
13.29
Extreme 13.29
68.32
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 16-12-31
President 47 21-02-28
Director of Finance/CFO 58 19-04-30
Members of the board TitleAgeSince
Director/Board Member 67 10-04-30
Director/Board Member 61 19-09-30
Director/Board Member 75 16-12-15
More insiders
Date Price Change Volume
24-03-28 38.15 +0.42% 695,603
24-03-27 37.99 +2.56% 884,823
24-03-26 37.04 +0.11% 640,191
24-03-25 37 -0.64% 870,832
24-03-22 37.24 +0.51% 669,528

Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT

More quotes
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
38.15 USD
Average target price
46.9 USD
Spread / Average Target
+22.94%
Consensus
  1. Stock
  2. Equities
  3. Stock Progyny, Inc. - Nasdaq